Ellsworth Fund Ltd. Announces Earnings and Financial Update

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Ellsworth Fund Ltd. Announces Earnings and Financial Update

MORRISTOWN, NJ--(Marketwired - May 2, 2013) - Ellsworth Fund Ltd. ( NYSE MKT : ECF ) today reported earnings, financial highlights and certain portfolio information for the six months ended March 31, 2013:

   
   
EARNINGS REPORT Six Months Ended
  March 31
     
  2013 2012
     
Net Income $1,445,000 $1,634,000
  Per Share $0.11 $0.12
Shares Outstanding 13,507,882 13,453,777
Total Net Assets $121,227,000 $113,626,000
Net Asset Value Per Share $8.97 $8.45
     
FUND STATISTICS    
     
Market price $7.64  
Net asset value (NAV) $8.97  
Premium/(Discount) (14.83)%  
Total Net Assets $121,227,000  
12-Month income    
  distribution $0.2630  
Yield on market price 3.44%  
Ratio of expenses (annualized) 1.14%  
Ratio of net income (annualized) 2.50%  
Portfolio turnover 23.47%  
Shares outstanding 13,507,882  
     
TOP TEN HOLDINGS    
  by underlying common stock    
  % of Net Assets  
Gilead Sciences, Inc. 3.1  
Verizon Communications Inc. 2.4  
AT&T Inc. 2.1  
Wells Fargo & Co. 2.1  
United Technologies Corp. 2.0  
Intel Corp. 1.8  
EMC Corp. 1.7  
Bank of America Corp. 1.6  
Amtrust Financial Services, Inc. 1.5  
Nuance Communications, Inc. 1.5  
     
MAJOR INDUSTRY EXPOSURE    
  % of Net Assets  
Semiconductors & Semiconductor Equipment 7.8  
Software 6.9  
Pharmaceuticals 6.8  
Diversified Telecommunications Services 5.1  
Biotechnology 5.0  
Oil, Gas & Consumable Fuels 5.0  
Commercial Banks 4.6  
Insurance 4.3  
Metals & Mining 4.2  
Real Estate Investment Trusts 3.6  
     
ASSET ALLOCATION    
  % of Net Assets  
Convertible Bonds & Notes 59.9  
Convertible Preferred Stock 11.9  
Mandatory Convertible Securities 9.9  
Common Stock 14.5  
Cash & Equivalents 3.8  
     
     

Data is unaudited and as of March 31, 2013. This selected information should be read in conjunction with the financial statements and notes included in the Company's Annual Report to Shareholders for the twelve months ended September 30, 2012.

Detailed portfolio information is available on our website ( www.ellsworthfund.com ).

Contact us by email at info@ellsworthfund.com or call us at (973) 631-1177.

Ellsworth Fund Ltd. operates as a closed-end, diversified management investment company and invests primarily in convertible securities, with the objectives of providing income and the potential for capital appreciation; which objectives the Fund considers to be relatively equal, over the long-term, due to the nature of the securities in which it invests. Its shares are traded on the NYSE MKT LLC under the ticker symbol ECF.

Cusip 289074106

For further information please contact: Gary I. Levine, Chief Financial Officer Ph. (973) 631-1177 Fax (973) 631-9893 info@ellsworthfund.com www.ellsworthfund.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CourseArc Partners with Colleges for ADA Compliance

Updated Category News Views 4

CourseArc's Landmark Deal with Public Colleges Well, slap me silly and call me a believer—looks like CourseArc just locked down a heck of a gig with a public college system that's head-over-heels squirming to meet shiny new accessibility demands. Nearly 200,000 learners are waiting at their gates, and this agreement is the lifeline for colleges to not only stay afloat...

Continue Reading
Kat Florence Hotels Offers Unique $20K Wine Tastings

Updated Category News Views 3

Luxury Retreat Offering Free Rare Wine Tastings The world of high-end hospitality just got a bit more intoxicating, literally. As of October 20, guests at the Elora luxury retreat, part of the Kat Florence Hotels portfolio, can indulge in some of the most coveted wines on the planet—gratis. That's right, wine aficionados can thank Kat Florence's latest extravagant...

Continue Reading
Sun Pharma's UNLOXCYT Gains NCCN Category 2A Nod

Updated Category News Views 9

UNLOXCYT: A New Player in Cancer Treatment Well, here's a notch up for Sun Pharma. Their UNLOXCYT® (cosibelimab-ipdl) just got a Category 2A Preferred Designation from the NCCN for locally advanced cutaneous squamous cell carcinoma (laCSCC) patients who can't opt for surgery or radiation. And if you know anything about cancer treatment guidelines, you know that's a big...

Continue Reading
JELD-WEN Schedules Q3 2026 Earnings Call Amid Global Reach

Updated Category News Views 9

Looking Ahead: JELD-WEN's Q3 Results Exploration Alright folks, buckle up. JELD-WEN Holding, Inc., the name any DIY'er worth their salt recognizes for doors and windows, has set the stage for unveiling its third quarter 2026 performance. They've earmarked November 3 post-market for us to comb through the numbers, and they're wasting no time by getting on a conference call...

Continue Reading
Sun Home Saunas Earns Top Workplace Honors in Retail

Updated Category News Views 3

In an age where corporate values often seem like lip service, Sun Home Saunas is showing the world what truly being a great place to work means—and they're getting recognized for it. Fortune has placed the sauna and cold plunge company at No. 17 on its 2026 Best Workplaces in Retail list. This ain't just fluff. We're talking about real employees, 100% of them, touting...

Continue Reading
University of Phoenix Lowers Costs for Transfer Students

Updated Category News Views 5

The Pocket-Saving Game of Transfer Credits Here's the buzz: the University of Phoenix is putting some serious coin back into students' pockets through transfer credits. We're looking at more than $12,010 in savings per student, thanks to these policies, which is no chump change by any stretch. As over 900,000 credits were tossed into the pot, the savings side of education...

Continue Reading
Freight Rebound Sparks Strategic M&A Opportunities

Updated Category News Views 7

Is the Freight Recovery Here to Stay? Just when you thought trucking might have run out of gas, we're hitting a sharp turn back into growth town. For those of you dropping equity crumbs every which way but loose in the last few years, this freight lull has been brutal—like the hangover from hell. But Brown Gibbons Lang & Company’s fresh report now hints at a brighter...

Continue Reading
Primoris Faces Allegations Over Misleading Project Costs

Updated Category News Views 0

Primoris in the Legal Crosshairs Here's something that's bound to rile up any investor keeping tabs on NYSE: PRIM like it's their personal stock ticker. Apparently, Primoris Services Corporation has found itself neck-deep in some murky waters. This time, it's law firm Moore Law PLLC that's raising the alarm bells, calling on shareholders to step into the legal ring....

Continue Reading
Trive Cashes Out on EarthLink, New Era with Family Offices

Updated Category News Views 1

EarthLink's Changing Hands: What's the Real Deal? I tell you, the tech industry's like a game of hot potato, and right now, EarthLink's the spud getting tossed around. Trive Capital, the private equity force from Dallas, just wrapped up handing EarthLink over to a family office squad. That's WaveDivision Capital, The Pritzker Organization, and Stephens Capital Partners...

Continue Reading
Florida Poly's Astro: First Flying Police Vehicle Takes Off

Updated Category News Views 8

Flying Into A New Era of Campus Safety Hold onto your hats, folks, because we're catapulting straight into the future. Florida Polytechnic University just rolled out something straight from sci-fi flicks—a flying police car. Yep, you heard right. They've dubbed it 'Astro,' after that lovable pooch from the Jetsons. Pioneering Advanced Air Mobility The Florida...

Continue Reading

Top 5 Most Recently Viewed Articles

Transform Your Investment Strategy with Canadian Natural Res

Updated Category News Views 154

Understanding the Growth of Canadian Natural Resources Over the past five years, Canadian Natural Resources Limited (NYSE: CNQ) has demonstrated incredible growth potential, surpassing market returns by an impressive 10.3% annually. This equates to an average annual return of 24.46%, highlighting the company's strong performance amidst market fluctuations. With a market...

Continue Reading
Medpace Holdings Sees Impressive Surge in Stock Value

Updated Category News Views 161

Medpace Holdings Experiences Stock Surge Shares of Medpace Holdings, Inc. (NASDAQ: MEDP) have seen a substantial increase of approximately 44.7%, reaching a price of $445.00 in pre-market trading. This impressive rise comes in the wake of strong financial results reported for the second quarter, which have undeniably stirred up excitement among investors. Financial...

Continue Reading
BCP's Covered Bonds: Morningstar DBRS Rating Termination Update

Updated Category News Views 278

Introduction to Banco Comercial Português and Its Bonds Banco Comercial Português, S.A. (Euronext Lisbon: BCP) has recently announced a significant development regarding its Covered Bonds. The news pertains to the termination of a rating assignment previously provided by Morningstar DBRS. Ratings are crucial in assessing the credibility and reliability of financial...

Continue Reading
Cerence AI Expands Leadership Team with Key Stock Grants

Updated Category News Views 221

Cerence AI Expands Leadership Team with Key Stock Grants Introduction to Cerence AI Cerence Inc. (NASDAQ: CRNC), based in Burlington, Massachusetts, stands out as a pioneering force in artificial intelligence tailored for the transportation sector. This innovative company focuses on delivering intuitive, AI-driven experiences that seamlessly integrate into vehicles,...

Continue Reading
Understanding Market Dynamics Surrounding Bristol-Myers Squibb

Updated Category News Views 153

Market Sentiment and Bristol-Myers Squibb Co Bristol-Myers Squibb Co (NYSE:BMY) has recently seen a notable increase in its short interest, climbing by 6.04% according to the latest data from exchanges. Presently, about 32.07 million shares are short-sold, representing 1.58% of its available trading shares. This situation poses the question of how long it might take...

Continue Reading